Alkermes plc (ALKS)
NASDAQ: ALKS · IEX Real-Time Price · USD
24.83
+0.18 (0.73%)
At close: Jul 19, 2024, 4:00 PM
24.77
-0.06 (-0.24%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Alkermes Revenue
Alkermes had revenue of $1.73B in the twelve months ending March 31, 2024, with 54.01% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $350.37M with 21.83% year-over-year growth. In the year 2023, Alkermes had annual revenue of $1.66B with 49.61% growth.
Revenue (ttm)
$1.73B
Revenue Growth
+54.01%
P/S Ratio
2.43
Revenue / Employee
$821,991
Employees
2,100
Market Cap
4.20B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.66B | 551.61M | 49.61% |
Dec 31, 2022 | 1.11B | -61.96M | -5.28% |
Dec 31, 2021 | 1.17B | 135.00M | 13.00% |
Dec 31, 2020 | 1.04B | -132.19M | -11.29% |
Dec 31, 2019 | 1.17B | 76.67M | 7.01% |
Dec 31, 2018 | 1.09B | 190.90M | 21.13% |
Dec 31, 2017 | 903.37M | 157.68M | 21.15% |
Dec 31, 2016 | 745.69M | 117.36M | 18.68% |
Dec 31, 2015 | 628.34M | 9.55M | 1.54% |
Dec 31, 2014 | 618.79M | 43.24M | 7.51% |
Mar 31, 2013 | 575.55M | 185.57M | 47.59% |
Mar 31, 2012 | 389.98M | 203.34M | 108.95% |
Mar 31, 2011 | 186.64M | 8.36M | 4.69% |
Mar 31, 2010 | 178.28M | -148.56M | -45.45% |
Mar 31, 2009 | 326.84M | 86.12M | 35.78% |
Mar 31, 2008 | 240.72M | 752.00K | 0.31% |
Mar 31, 2007 | 239.97M | 73.36M | 44.04% |
Mar 31, 2006 | 166.60M | 90.48M | 118.85% |
Mar 31, 2005 | 76.13M | 37.07M | 94.92% |
Mar 31, 2004 | 39.05M | -8.21M | -17.37% |
Mar 31, 2003 | 47.27M | -6.84M | -12.63% |
Mar 31, 2002 | 54.10M | -1.93M | -3.44% |
Mar 31, 2001 | 56.03M | 33.11M | 144.45% |
Mar 31, 2000 | 22.92M | -10.97M | -32.37% |
Mar 31, 1999 | 33.89M | 8.31M | 32.47% |
Mar 31, 1998 | 25.59M | 5.76M | 29.04% |
Mar 31, 1997 | 19.83M | 3.91M | 24.55% |
Mar 31, 1996 | 15.92M | 2.02M | 14.49% |
Mar 31, 1995 | 13.90M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
RadNet | 1.66B |
Integer Holdings | 1.63B |
Haemonetics | 1.31B |
Inspire Medical Systems | 660.91M |
Axsome Therapeutics | 251.02M |
Avidity Biosciences | 10.87M |
Crinetics Pharmaceuticals | 1.97M |
ImmunityBio | 302.00K |
ALKS News
- 4 days ago - Alkermes to Report Second Quarter Financial Results on July 24, 2024 - PRNewsWire
- 6 weeks ago - Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024 - PRNewsWire
- 7 weeks ago - Alkermes to Participate in Two Upcoming Investor Conferences - PRNewsWire
- 7 weeks ago - Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024 - PRNewsWire
- 2 months ago - Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences - PRNewsWire
- 2 months ago - Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk - PRNewsWire
- 2 months ago - Alkermes plc Reports First Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1 - PRNewsWire